Person Prof Kenneth Bradstock National Health and Medical Research Council Viewed: [[ro.stat.viewed]] Click to explore relationships graph Help Related Grants and Projects $relation_to_title = []; $dupes = 0;?> Participant in A Phase 1 Clinical Trial of a Human Chimeric Anti-Activated DC Antibody to Prevent AGVHD in high risk allo HSCT. (funded by National Health and Medical Research Council) Participant in A randomised study to optimise clinical outcomes in patients with FLT3 mutant AML (funded by National Health and Medical Research Council) Principal investigator of A randomised trial of high dose Cytarabine in initial therapy for acute myeloid leukaemia (funded by National Health and Medical Research Council) Principal investigator of A randomized trial of Idarubicin dose escalation in consolidation therapy for adult acute myeloid leukemia (funded by National Health and Medical Research Council) Participant in Activated Dendritic Cell Monoclonal Antibodies as Therapeutics to Prevent Graft Versus Host Disease (funded by National Health and Medical Research Council) View all 12 related grants and projects User Contributed Tags Login to tag this record with meaningful keywords to make it easier to discover Saved to MyRDA Save to MyRDA
Click to explore relationships graph Help Related Grants and Projects $relation_to_title = []; $dupes = 0;?> Participant in A Phase 1 Clinical Trial of a Human Chimeric Anti-Activated DC Antibody to Prevent AGVHD in high risk allo HSCT. (funded by National Health and Medical Research Council) Participant in A randomised study to optimise clinical outcomes in patients with FLT3 mutant AML (funded by National Health and Medical Research Council) Principal investigator of A randomised trial of high dose Cytarabine in initial therapy for acute myeloid leukaemia (funded by National Health and Medical Research Council) Principal investigator of A randomized trial of Idarubicin dose escalation in consolidation therapy for adult acute myeloid leukemia (funded by National Health and Medical Research Council) Participant in Activated Dendritic Cell Monoclonal Antibodies as Therapeutics to Prevent Graft Versus Host Disease (funded by National Health and Medical Research Council) View all 12 related grants and projects User Contributed Tags Login to tag this record with meaningful keywords to make it easier to discover